器械治疗慢性完全闭塞病变——最佳治疗策略是什么？ - Suppr

Suppr

超能文献

Instent CTO-What Is the Best Treatment Strategy?

作者信息

Sahyouni Mark, Stouffer George A

机构信息

Campbell University School of Osteopathic Medicine, Lillington, NC, 27546, USA.

Division of Cardiology and McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, 27599-7075, USA.

出版信息

Cardiovasc Drugs Ther. 2024 Jun;38(3):393-394. doi: 10.1007/s10557-024-07556-2. Epub 2024 Jan 25.

DOI:10.1007/s10557-024-07556-2

PMID:38270692

Abstract

摘要

相似文献

Instent CTO-What Is the Best Treatment Strategy?器械治疗慢性完全闭塞病变——最佳治疗策略是什么？

Cardiovasc Drugs Ther. 2024 Jun;38(3):393-394. doi: 10.1007/s10557-024-07556-2. Epub 2024 Jan 25.

The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry.Hybrid 策略在慢性完全闭塞经皮冠状动脉介入治疗中的应用：来自 PROGRESS CTO 注册研究的更新。

JACC Cardiovasc Interv. 2018 Jul 23;11(14):1325-1335. doi: 10.1016/j.jcin.2018.02.036. Epub 2018 Apr 26.

Transvenous IVUS-guided percutaneous coronary intervention for chronic total occlusion: a novel strategy.经静脉血管内超声引导下经皮冠状动脉介入治疗慢性完全闭塞病变：一种新策略。

J Invasive Cardiol. 2013 Jul;25(7):E143-6.

Latest developments in chronic total occlusion percutaneous coronary intervention.慢性完全闭塞性经皮冠状动脉介入治疗的最新进展

Expert Rev Cardiovasc Ther. 2020 Jul;18(7):415-426. doi: 10.1080/14779072.2020.1787153. Epub 2020 Jul 13.

Coronary Computed Tomography Angiography Predicts Guidewire Crossing and Success of Percutaneous Intervention for Chronic Total Occlusion: Korean Multicenter CTO CT Registry Score as a Tool for Assessing Difficulty in Chronic Total Occlusion Percutaneous Coronary Intervention.冠状动脉计算机断层扫描血管造影术预测慢性完全闭塞病变经皮介入治疗的导丝通过情况及成功率：韩国多中心慢性完全闭塞病变CT注册研究评分作为评估慢性完全闭塞病变经皮冠状动脉介入治疗难度的工具

Circ Cardiovasc Imaging. 2017 Apr;10(4). doi: 10.1161/CIRCIMAGING.116.005800.

Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study.经皮冠状动脉介入治疗与药物治疗对冠状动脉慢性完全闭塞患者生存获益的比较：一项 10 年随访研究。

J Am Heart Assoc. 2021 Mar 16;10(6):e019022. doi: 10.1161/JAHA.120.019022. Epub 2021 Mar 4.

Long-Term Outcomes of Percutaneous Coronary Intervention for Patients With In-Stent Chronic Total Occlusion Versus De Novo Chronic Total Occlusion.经皮冠状动脉介入治疗支架内慢性完全闭塞与初发慢性完全闭塞患者的长期结果。

Angiology. 2021 Sep;72(8):740-748. doi: 10.1177/0003319721998575. Epub 2021 Mar 4.

Procedural and Long-Term Outcomes of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion.经皮冠状动脉介入治疗支架内慢性完全闭塞的操作及长期结果。

JACC Cardiovasc Interv. 2017 May 8;10(9):892-902. doi: 10.1016/j.jcin.2017.01.047. Epub 2017 Apr 12.

Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry.原发性逆行策略在慢性完全闭塞经皮冠状动脉介入治疗中成功的预测因素：来自 PROGRESS-慢性完全闭塞登记处的见解。

Catheter Cardiovasc Interv. 2022 Jul;100(1):19-27. doi: 10.1002/ccd.30228. Epub 2022 May 26.

Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions: The PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score.一种新型评分系统用于预测慢性完全闭塞经皮冠状动脉介入治疗技术成功的开发和验证：PROGRESS CTO（慢性完全闭塞介入治疗前瞻性全球注册研究）评分。

JACC Cardiovasc Interv. 2016 Jan 11;9(1):1-9. doi: 10.1016/j.jcin.2015.09.022.

本文引用的文献

Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion.紫杉醇涂层球囊血管成形术与药物洗脱支架置入术治疗冠状动脉药物洗脱支架内慢性完全闭塞的临床转归。

Cardiovasc Drugs Ther. 2023 Dec;37(6):1155-1166. doi: 10.1007/s10557-022-07363-7. Epub 2022 Aug 5.

Coronary In-Stent Restenosis: JACC State-of-the-Art Review.冠状动脉支架内再狭窄：JACC 最新综述

J Am Coll Cardiol. 2022 Jul 26;80(4):348-372. doi: 10.1016/j.jacc.2022.05.017.

A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data.多中心注册研究数据比较支架内再狭窄慢性完全闭塞和初发慢性完全闭塞患者的介入治疗成功率和长期临床结局。

Clin Res Cardiol. 2020 May;109(5):628-637. doi: 10.1007/s00392-019-01550-7. Epub 2019 Sep 24.

Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study).紫杉醇涂层球囊血管成形术与药物洗脱支架治疗冠状动脉支架内再狭窄的比较：10项随机临床试验的综合、协作、个体患者数据荟萃分析（代达罗斯研究）

Eur Heart J. 2020 Oct 7;41(38):3715-3728. doi: 10.1093/eurheartj/ehz594.

Clinical Outcomes of Drug-Eluting Balloon for In-Stent Restenosis Based on the Number of Metallic Layers.基于金属层数的药物洗脱球囊治疗支架内再狭窄的临床转归。

Circ Cardiovasc Interv. 2018 Aug;11(8):e005935. doi: 10.1161/CIRCINTERVENTIONS.117.005935.

2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。

Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验